{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:43:00Z","timestamp":1792788180038,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Vellore Institute of Technology, Vellore"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The World Health Organization (WHO) has identified neurological disorders (NDs) as one of the major health concerns worldwide, resulting in high mortality rates. NDs are conditions affecting the central and peripheral nervous systems, including the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, neuromuscular junctions, and muscles. These neurological diseases include Alzheimer\u2019s disease, Parkinson\u2019s disease, glioma\/brain cancer, Huntington\u2019s disease, amyotrophic lateral sclerosis, multiple sclerosis, neuroinfections, ischemic stroke, trauma, hypoxia\/anoxia, and depression. Unfortunately, these disorders remain difficult to treat due to the limited ability of conventional drugs to cross the blood\u2013brain barrier (BBB) and achieve significant pharmacological effects in the brain. There is an urgent need to develop methods that can enhance drug efficacy and bypass the BBB. The application of various nanomaterials represents a promising approach to address these neurological disorders. Drugs incorporated with nanomaterials help improve therapeutic outcomes, reduce toxicity, provide better stability, enable targeted delivery, and enhance drug loading capacity. Numerous types and morphologies of inorganic and organic nanomaterials are increasingly employed for treating NDs, including quantum dots, dendrimers, metal nanoparticles, polymeric nanoparticles, liposomes, carbon nanotubes, metal oxide nanoparticles, and micelles. Their exceptional properties such as sensitivity, selectivity, and potential to bypass the BBB make them suitable for both diagnosis and treatment of NDs. In this review article, we briefly summarize the etiology and pathophysiology of various NDs along with current literature highlighting the use of nanomaterials for treating neurological disorders.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12967-025-06877-6","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T10:15:20Z","timestamp":1764584120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nanomaterials: an overview of current trends and future prospects in neurological disorder treatment"],"prefix":"10.1186","volume":"23","author":[{"given":"Deboral","family":"Eshak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1647-3182","authenticated-orcid":false,"given":"Mohanapriya","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"6877_CR1","volume-title":"World stroke day","author":"World Health Organization (WHO)","year":"2021","unstructured":"World Health Organization (WHO). World stroke day. South-East Asia: WHO Press; 2021."},{"key":"6877_CR2","volume-title":"Neurological disorders: public health challenges","author":"World Health Organization (WHO)","year":"2006","unstructured":"World Health Organization (WHO). Neurological disorders: public health challenges. Geneva: WHO Press; 2006."},{"issue":"1","key":"6877_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.maturitas.2011.12.015","volume":"73","author":"F Re","year":"2012","unstructured":"Re F, Gregori M, Masserini M. Nanotechnology for neurodegenerative disorders. Maturitas. 2012;73(1):45\u201351. https:\/\/doi.org\/10.1016\/j.maturitas.2011.12.015.","journal-title":"Maturitas"},{"issue":"5","key":"6877_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1242\/dmm.030205","volume":"10","author":"AD Gitler","year":"2017","unstructured":"Gitler AD, Dhillon P, Shorter J. Neurodegenerative disease: models, mechanisms, and a new hope. Dis Model Mech. 2017;10(5):499\u2013502. https:\/\/doi.org\/10.1242\/dmm.030205.","journal-title":"Dis Model Mech"},{"key":"6877_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.805786","author":"J Kim","year":"2022","unstructured":"Kim J, Erice C, Rohlwink UK, Tucker EW. Infections in the developing brain: the role of the neuro-immune axis. Front Neurol. 2022. https:\/\/doi.org\/10.3389\/fneur.2022.805786.","journal-title":"Front Neurol"},{"issue":"5","key":"6877_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1212\/CPJ.0000000000000517","volume":"8","author":"D Imran","year":"2018","unstructured":"Imran D, Estiasari R, Maharani K, Sucipto, Lestari DC, Yunus RE, Yunihastuti E, Karyadi TH, Oei D, Timan IS, Wulandari D, Wahyuningsih R, Adawiyah R, Kurniawan A, Mulyadi R, Karuniawati A, Jaya UA, Safari D, van Laarhoven A, van Crevel R. Presentation, etiology, and outcome of brain infections in an Indonesian hospital: a cohort study. Neurol Clin Pract. 2018;8(5):379\u201388. https:\/\/doi.org\/10.1212\/CPJ.0000000000000517.","journal-title":"Neurol Clin Pract"},{"key":"6877_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010234","author":"Y le Govic","year":"2022","unstructured":"le Govic Y, Demey B, Cassereau J, Bahn YS, Papon N. Pathogens infecting the central nervous system. PLoS Pathog. 2022. https:\/\/doi.org\/10.1371\/journal.ppat.1010234.","journal-title":"PLoS Pathog"},{"key":"6877_CR8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2200960119","author":"F Crunfli","year":"2022","unstructured":"Crunfli F, Carregari VC, Veras FP, Silva LS, Nogueira MH, Antunes ASLM, Vendramini PH, Valen\u00e7a AGF, Brand\u00e3o-Teles C, da Silva Zuccoli G, Reis-De-Oliveira G, Silva-Costa LC, Saia-Cereda VM, Smith BJ, Codo AC, de Souza GF, Muraro SP, Parise PL, Toledo-Teixeira DA, Martins-De-Souza D. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proc Natl Acad Sci United States Am. 2022. https:\/\/doi.org\/10.1073\/pnas.2200960119.","journal-title":"Proc Natl Acad Sci United States Am"},{"issue":"9648","key":"6877_CR9","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A. Multiple sclerosis. The Lancet. 2008;372(9648):1502\u201317. https:\/\/doi.org\/10.1016\/S0140-6736(08)61620-7.","journal-title":"The Lancet"},{"issue":"1","key":"6877_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood\u2013brain barrier. Neurobiol Dis. 2010;37(1):13\u201325. https:\/\/doi.org\/10.1016\/j.nbd.2009.07.030.","journal-title":"Neurobiol Dis"},{"issue":"9497","key":"6877_CR11","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes RA, Cornblath DR. Guillain-Barr\u00e9 syndrome. The Lancet. 2005;366(9497):1653\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(05)67665-9.","journal-title":"The Lancet"},{"issue":"1","key":"6877_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1529-8027.2012.00378.x","volume":"17","author":"DW Zochodne","year":"2012","unstructured":"Zochodne DW. The challenges and beauty of peripheral nerve regrowth. J Peripher Nerv Syst. 2012;17(1):1\u201318. https:\/\/doi.org\/10.1111\/j.1529-8027.2012.00378.x.","journal-title":"J Peripher Nerv Syst"},{"issue":"9427","key":"6877_CR13","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/S0140-6736(04)16508-2","volume":"363","author":"JD England","year":"2004","unstructured":"England JD, Asbury AK. Peripheral neuropathy. The Lancet. 2004;363(9427):2151\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(04)16508-2.","journal-title":"The Lancet"},{"key":"6877_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6564585","author":"A Alahmari","year":"2021","unstructured":"Alahmari A. Blood-brain barrier overview: structural and functional correlation. Neural Plast. 2021. https:\/\/doi.org\/10.1155\/2021\/6564585.","journal-title":"Neural Plast"},{"key":"6877_CR15","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a020412","author":"R Daneman","year":"2015","unstructured":"Daneman R, Prat A. The blood\u2013brain barrier. Cold Spring Harb Perspect Biol. 2015. https:\/\/doi.org\/10.1101\/cshperspect.a020412.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"6877_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-020-00230-3","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo L. A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020. https:\/\/doi.org\/10.1186\/s12987-020-00230-3.","journal-title":"Fluids Barriers CNS"},{"issue":"6","key":"6877_CR17","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","volume":"27","author":"EG Knox","year":"2022","unstructured":"Knox EG, Aburto MR, Clarke G, Cryan JF, O\u2019Driscoll CM. The blood-brain barrier in aging and neurodegeneration. Mol Psychiatry. 2022;27(6):2659\u201373. https:\/\/doi.org\/10.1038\/s41380-022-01511-z.","journal-title":"Mol Psychiatry"},{"key":"6877_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00719-9","author":"L Zhang","year":"2021","unstructured":"Zhang L, Zhou L, Bao L, Liu J, Zhu H, Lv Q, Liu R, Chen W, Tong W, Wei Q, Xu Y, Deng W, Gao H, Xue J, Song Z, Yu P, Han Y, Zhang Y, Sun X, Qin C. SARS-CoV-2 crosses the blood\u2013brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct Target Therapy. 2021. https:\/\/doi.org\/10.1038\/s41392-021-00719-9.","journal-title":"Signal Transduct Target Therapy"},{"key":"6877_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00953","author":"NP Pampaloni","year":"2019","unstructured":"Pampaloni NP, Giugliano M, Scaini D, Ballerini L, Rauti R. Advances in nano neuroscience: from nanomaterials to nanotools. Front Neurosci. 2019. https:\/\/doi.org\/10.3389\/fnins.2018.00953.","journal-title":"Front Neurosci"},{"issue":"2","key":"6877_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","volume":"160","author":"Y Barenholz","year":"2012","unstructured":"Barenholz Y. Doxil\u00ae\u2014The first FDA-approved nano-drug: Lessons learned. J Control Release. 2012;160(2):117\u201334. https:\/\/doi.org\/10.1016\/j.jconrel.2012.03.020.","journal-title":"J Control Release"},{"key":"6877_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva C, Pra\u00e7a C, Ferreira R, Santos T, Ferreira L, Bernardino L. Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release. 2016;235:34\u201347. https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.044.","journal-title":"J Control Release"},{"issue":"2","key":"6877_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/nano.2007.2.2.129","volume":"2","author":"SK Murthy","year":"2007","unstructured":"Murthy SK. Nanoparticles in modern medicine: state of the art and future challenges. Int J Nanomed. 2007;2(2):129\u201341. https:\/\/doi.org\/10.2147\/nano.2007.2.2.129.","journal-title":"Int J Nanomed"},{"key":"6877_CR23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jconrel.2020.10.053","volume":"328","author":"Z Hussain","year":"2020","unstructured":"Hussain Z, Thu HE, Elsayed I, Abourehab MAS, Khan S, Sohail M, Sarfraz RM, Farooq MA. Nano-scaled materials may induce severe neurotoxicity upon chronic exposure to brain tissues: a critical appraisal and recent updates on predisposing factors, underlying mechanism, and future prospects. J Control Release. 2020;328:873\u201394. https:\/\/doi.org\/10.1016\/j.jconrel.2020.10.053.","journal-title":"J Control Release"},{"key":"6877_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/B978-0-12-814001-7.00013-5","volume-title":"Brain targeted drug delivery systems: a focus on nanotechnology and nanoparticulates","author":"M Huang","year":"2018","unstructured":"Huang M, Gu X, Gao X. Nanotherapeutic strategies for the treatment of neurodegenerative diseases. In: Brain targeted drug delivery systems: a focus on nanotechnology and nanoparticulates. Amsterdam: Elsevier; 2018. p. 321\u201356. https:\/\/doi.org\/10.1016\/B978-0-12-814001-7.00013-5."},{"issue":"7","key":"6877_CR25","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.2217\/nnm.14.206","volume":"10","author":"M Gregori","year":"2015","unstructured":"Gregori M, Masserini M, Mancini S. Nanomedicine for the treatment of Alzheimer\u2019s disease. Nanomedicine. 2015;10(7):1203\u201318. https:\/\/doi.org\/10.2217\/nnm.14.206.","journal-title":"Nanomedicine"},{"key":"6877_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep42871","author":"DA Gonzalez-Carter","year":"2017","unstructured":"Gonzalez-Carter DA, Leo BF, Ruenraroengsak P, Chen S, Goode AE, Theodorou IG, Chung KF, Carzaniga R, Shaffer MSP, Dexter DT, Ryan MP, Porter AE. Silver nanoparticles reduce brain inflammation and related neurotoxicity through induction of H 2 S-synthesizing enzymes. Sci Rep. 2017. https:\/\/doi.org\/10.1038\/srep42871.","journal-title":"Sci Rep"},{"key":"6877_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.788128","author":"SA Annu","year":"2022","unstructured":"Annu SA, Qamar Z, Md S, Alhakamy NA, Baboota S, Ali J. An insight to brain targeting utilizing polymeric nanoparticles: effective treatment modalities for neurological disorders and brain tumor. Front Bioeng Biotechnol. 2022. https:\/\/doi.org\/10.3389\/fbioe.2022.788128.","journal-title":"Front Bioeng Biotechnol"},{"issue":"11","key":"6877_CR28","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1021\/acsbiomaterials.2c00865","volume":"8","author":"D D\u00edaz-Garc\u00eda","year":"2022","unstructured":"D\u00edaz-Garc\u00eda D, Ferrer-Donato \u00c1, M\u00e9ndez-Arriaga JM, Cabrera-Pinto M, D\u00edaz-S\u00e1nchez M, Prashar S, Fernandez-Martos CM, G\u00f3mez-Ruiz S. Design of mesoporous silica nanoparticles for the treatment of amyotrophic lateral sclerosis (ALS) with a therapeutic cocktail based on leptin and pioglitazone. ACS Biomater Sci Eng. 2022;8(11):4838\u201349. https:\/\/doi.org\/10.1021\/acsbiomaterials.2c00865.","journal-title":"ACS Biomater Sci Eng"},{"issue":"39","key":"6877_CR29","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.2174\/0929867329666220527121943","volume":"29","author":"J Zhang","year":"2022","unstructured":"Zhang J, Yang T, Huang W, Yu Y, Sun T. Applications of gold nanoparticles in brain diseases across the blood-brain barrier. Curr Med Chem. 2022;29(39):6063\u201383. https:\/\/doi.org\/10.2174\/0929867329666220527121943.","journal-title":"Curr Med Chem"},{"issue":"12","key":"6877_CR30","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2174\/1389200222666210525123416","volume":"22","author":"KMA Farheen","year":"2021","unstructured":"Farheen KMA, Ashraf GM, Bilgrami AL, Rizvi MMA. New horizons in the treatment of neurological disorders with tailorable gold nanoparticles. Curr Drug Metab. 2021;22(12):931\u20138. https:\/\/doi.org\/10.2174\/1389200222666210525123416.","journal-title":"Curr Drug Metab"},{"issue":"8\u20139","key":"6877_CR31","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.progpolymsci.2007.05.014","volume":"32","author":"AV Kabanov","year":"2007","unstructured":"Kabanov AV, Gendelman HE. Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Progress Polym Sci. 2007;32(8\u20139):1054\u201382. https:\/\/doi.org\/10.1016\/j.progpolymsci.2007.05.014.","journal-title":"Progress Polym Sci"},{"key":"6877_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2047379","author":"K Wang","year":"2020","unstructured":"Wang K, Zhu X, Yu E, Desai P, Wang H, Zhang CL, Zhuge Q, Yang J, Hu J. Therapeutic nanomaterials for neurological diseases and cancer therapy. J Nanomater. 2020. https:\/\/doi.org\/10.1155\/2020\/2047379.","journal-title":"J Nanomater"},{"key":"6877_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/ppsc.201900195","author":"S Mendiratta","year":"2019","unstructured":"Mendiratta S, Hussein M, Nasser HA, Ali AAA. Multidisciplinary role of mesoporous silica nanoparticles in brain regeneration and cancers: from crossing the blood-brain barrier to treatment. Part Part Syst Charact. 2019. https:\/\/doi.org\/10.1002\/ppsc.201900195.","journal-title":"Part Part Syst Charact"},{"key":"6877_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/biology11030469","author":"AA Lima","year":"2022","unstructured":"Lima AA, Mridha MF, Das SC, Kabir MM, Islam MR, Watanobe Y. A comprehensive survey on the detection, classification, and challenges of neurological disorders. Biology. 2022. https:\/\/doi.org\/10.3390\/biology11030469.","journal-title":"Biology"},{"issue":"9","key":"6877_CR35","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1093\/brain\/awab147","volume":"144","author":"CC Gross","year":"2021","unstructured":"Gross CC, Schulte-Mecklenbeck A, Madireddy L, Pawlitzki M, Strippel C, R\u00e4uber S, Kr\u00e4mer J, Rolfes L, Ruck T, Beuker C, Schmidt-Pogoda A, Lohmann L, Schneider-Hohendorf T, Hahn T, Schwab N, Minnerup J, Melzer N, Klotz L, Meuth SG, Wiendl H. Classification of neurological diseases using multi-dimensional CSF analysis. Brain. 2021;144(9):2625\u201334. https:\/\/doi.org\/10.1093\/brain\/awab147.","journal-title":"Brain"},{"key":"6877_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10111845","author":"TMC Pereira","year":"2021","unstructured":"Pereira TMC, C\u00f4co LZ, Ton AMM, Meyrelles SS, Campos-Toimil M, Campagnaro BP, Vasquez EC. The emerging scenario of the gut\u2013brain axis: the therapeutic actions of the new actor kefir against neurodegenerative diseases. Antioxidants. 2021. https:\/\/doi.org\/10.3390\/antiox10111845.","journal-title":"Antioxidants"},{"key":"6877_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24081583","author":"A Singh","year":"2019","unstructured":"Singh A, Kukreti R, Saso L, Kukreti S. Oxidative stress: a key modulator in neurodegenerative diseases. Molecules. 2019. https:\/\/doi.org\/10.3390\/molecules24081583.","journal-title":"Molecules"},{"key":"6877_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10060338","author":"M Chountoulesi","year":"2020","unstructured":"Chountoulesi M, Demetzos C. Promising nanotechnology approaches in treatment of autoimmune diseases of central nervous system. Brain Sci. 2020. https:\/\/doi.org\/10.3390\/brainsci10060338.","journal-title":"Brain Sci"},{"issue":"10","key":"6877_CR39","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori P, van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27(10):1918\u201329. https:\/\/doi.org\/10.1111\/ene.14393.","journal-title":"Eur J Neurol"},{"key":"6877_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.1042986","author":"Y Cao","year":"2022","unstructured":"Cao Y, Zhang R. The application of nanotechnology in treatment of Alzheimer\u2019s disease. Front Bioeng Biotechnol. 2022. https:\/\/doi.org\/10.3389\/fbioe.2022.1042986.","journal-title":"Front Bioeng Biotechnol"},{"key":"6877_CR41","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.369096","author":"A Unnisa","year":"2023","unstructured":"Unnisa A, Greig N, Kamal M. Nanotechnology-based gene therapy as a credible tool in the treatment of Alzheimer\u2019s disease. Neural Regen Res. 2023. https:\/\/doi.org\/10.4103\/1673-5374.369096.","journal-title":"Neural Regen Res"},{"key":"6877_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14040835","author":"P Poudel","year":"2022","unstructured":"Poudel P, Park S. Recent advances in the treatment of Alzheimer\u2019s disease using nanoparticle-based drug delivery systems. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14040835.","journal-title":"Pharmaceutics"},{"issue":"3","key":"6877_CR43","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/mds.22987","volume":"25","author":"J Linder","year":"2010","unstructured":"Linder J, Stenlund H, Forsgren L. Incidence of Parkinson\u2019s disease and Parkinsonism in northern Sweden: a population-based study. Mov Disord. 2010;25(3):341\u20138. https:\/\/doi.org\/10.1002\/mds.22987.","journal-title":"Mov Disord"},{"key":"6877_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00612","author":"FN Emamzadeh","year":"2018","unstructured":"Emamzadeh FN, Surguchov A. Parkinson\u2019s disease: Biomarkers, treatment, and risk factors. Front Neurosci. 2018. https:\/\/doi.org\/10.3389\/fnins.2018.00612.","journal-title":"Front Neurosci"},{"issue":"2","key":"6877_CR45","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1176\/jnp.14.2.223","volume":"14","author":"J Parkinson","year":"2002","unstructured":"Parkinson J. Neuropsychiatry classics an ESSAY on the shaking palsy member of the Royal College of Surgeons preface. J Neuropsychiatry Clin Neurosci. 2002;14(2):223\u201336.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"6877_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2020.100056","author":"EM Gatto","year":"2020","unstructured":"Gatto EM, Rojas NG, Persi G, Etcheverry JL, Cesarini ME, Perandones C. Huntington disease: advances in the understanding of its mechanisms. Clin Parkinsonism Related Disord. 2020. https:\/\/doi.org\/10.1016\/j.prdoa.2020.100056.","journal-title":"Clin Parkinsonism Related Disord"},{"key":"6877_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168363","author":"A Kim","year":"2021","unstructured":"Kim A, Lalonde K, Truesdell A, Welter PG, Brocardo PS, Rosenstock TR, Gil-mohapel J. New avenues for the treatment of Huntington\u2019s disease. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22168363.","journal-title":"Int J Mol Sci"},{"key":"6877_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e07994","author":"H Nsairat","year":"2021","unstructured":"Nsairat H, Khater D, Odeh F, Al-Adaileh F, Al-Taher S, Jaber AM, Alshaer W, al Bawa A, Mubarak MS. Lipid nanostructures for targeting brain cancer. Heliyon. 2021. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07994.","journal-title":"Heliyon"},{"issue":"2","key":"6877_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22020924","volume":"22","author":"A Finch","year":"2021","unstructured":"Finch A, Solomou G, Wykes V, Pohl U, Bardella C, Watts C. Advances in research of adult gliomas. Int J Mol Sci. 2021;22(2):1\u201336. https:\/\/doi.org\/10.3390\/ijms22020924.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"6877_CR50","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1212\/WNL.0000000000004856","volume":"90","author":"AJ Price","year":"2018","unstructured":"Price AJ, Wright FL, Green J, Balkwill A, Kan SW, Yang TYO, Floud S, Kroll ME, Simpson R, Sudlow CLM, Beral V, Reeves GK. Differences in risk factors for 3 types of strokes: UK prospective study and meta-analyses. Neurology. 2018;90(4):e298\u2013306. https:\/\/doi.org\/10.1212\/WNL.0000000000004856.","journal-title":"Neurology"},{"issue":"20","key":"6877_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21207609","volume":"21","author":"D Kuriakose","year":"2020","unstructured":"Kuriakose D, Xiao Z. Pathophysiology and treatment of stroke: present status and future perspectives. Int J Mol Sci. 2020;21(20):1\u201324. https:\/\/doi.org\/10.3390\/ijms21207609.","journal-title":"Int J Mol Sci"},{"key":"6877_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.mpmed.2020.06.002","author":"SJX Murphy","year":"2020","unstructured":"Murphy SJX, Werring DJ. Stroke: causes and clinical features. Medicine. 2020. https:\/\/doi.org\/10.1016\/j.mpmed.2020.06.002.","journal-title":"Medicine"},{"key":"6877_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-024-05098-9","author":"C Prajapati","year":"2025","unstructured":"Prajapati C, et al. An update of fungal endophyte diversity and strategies for augmenting therapeutic potential of their potent metabolites: recent advancement. Appl Biochem Biotechnol. 2025. https:\/\/doi.org\/10.1007\/s12010-024-05098-9.","journal-title":"Appl Biochem Biotechnol"},{"key":"6877_CR54","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA","author":"HA Rowley","year":"2013","unstructured":"Rowley HA. The alphabet of imaging in acute stroke does it spell improved selection and outcome? Stroke. 2013. https:\/\/doi.org\/10.1161\/STROKEAHA.","journal-title":"Stroke"},{"key":"6877_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-020-00658-7","author":"PS Chen","year":"2020","unstructured":"Chen PS, Chiu WT, Hsu PL, Lin SC, Peng IC, Wang CY, Tsai SJ. Pathophysiological implications of hypoxia in human diseases. J Biomed Sci. 2020. https:\/\/doi.org\/10.1186\/s12929-020-00658-7.","journal-title":"J Biomed Sci"},{"key":"6877_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1152\/physrev.00041.2017","volume":"99","author":"TP Keeley","year":"2019","unstructured":"Keeley TP, Mann GE. Defining physiological normoxia for improved translation of cell physiology to animal models and humans. Physiol Rev. 2019;99:161\u2013234. https:\/\/doi.org\/10.1152\/physrev.00041.2017.","journal-title":"Physiol Rev"},{"key":"6877_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/jof5030060","author":"J Velasco","year":"2019","unstructured":"Velasco J, Revankar S. CNS infections caused by brown-black fungi. J Fungi. 2019. https:\/\/doi.org\/10.3390\/jof5030060.","journal-title":"J Fungi"},{"key":"6877_CR58","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/0963689717714102","volume-title":"Handbook of secondary dementias","author":"D Burton","year":"2006","unstructured":"Burton D, Aisen M. Traumatic brain injury. In: Handbook of secondary dementias. Boca Raton: CRC Press; 2006. p. 83\u2013118. https:\/\/doi.org\/10.1177\/0963689717714102."},{"key":"6877_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00528","author":"SY Ng","year":"2019","unstructured":"Ng SY, Lee AYW. Traumatic brain injuries: pathophysiology and potential therapeutic targets. Front Cell Neurosci. 2019. https:\/\/doi.org\/10.3389\/fncel.2019.00528.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"6877_CR60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/bja\/aem131","volume":"99","author":"C Werner","year":"2007","unstructured":"Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth. 2007;99(1):4\u20139. https:\/\/doi.org\/10.1093\/bja\/aem131.","journal-title":"Br J Anaesth"},{"key":"6877_CR61","doi-asserted-by":"publisher","first-page":"879","DOI":"10.14233\/ajchem.2019.21817","volume":"31","author":"SPS Sri","year":"2019","unstructured":"Sri SPS, Vijayakumar A, George M. Synthesis, optical, morphological and magnetic properties of hematite nanorods in deep eutectic solvent with its antibacterial and photocatalytic applications. Asian J Chem. 2019;31:879\u201385. https:\/\/doi.org\/10.14233\/ajchem.2019.21817.","journal-title":"Asian J Chem"},{"key":"6877_CR62","doi-asserted-by":"publisher","first-page":"100609","DOI":"10.1016\/j.surfin.2020.100609","volume":"20","author":"SPS Sri","year":"2020","unstructured":"Sri SPS, Taj J, George M. Facile synthesis of magnetite nanocubes using deep eutectic solvent: an insight to anticancer and photo-Fenton efficacy. Surf Interfaces. 2020;20:100609. https:\/\/doi.org\/10.1016\/j.surfin.2020.100609.","journal-title":"Surf Interfaces"},{"key":"6877_CR63","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jmrt.2021.07.145","volume":"15","author":"VSPS Sri","year":"2021","unstructured":"Sri VSPS, et al. Unveiling the photosensitive and magnetic properties of amorphous iron nanoparticles with its application towards decontamination of water and cancer treatment. J Mater Res Technol. 2021;15:99\u2013118. https:\/\/doi.org\/10.1016\/j.jmrt.2021.07.145.","journal-title":"J Mater Res Technol"},{"issue":"1","key":"6877_CR64","first-page":"1","volume":"22","author":"L Shabani","year":"2023","unstructured":"Shabani L, Abbasi M, Azarnew Z, Amani AM, Vaez A. Neuro-nanotechnology: diagnostic and therapeutic nano-based strategies in applied neuroscience. Biomed Eng. 2023;22(1):1.","journal-title":"Biomed Eng"},{"issue":"3","key":"6877_CR65","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/pharmaceutics10030134","volume":"10","author":"MR Gigliobianco","year":"2018","unstructured":"Gigliobianco MR, Casadidio C, Censi R, Di Martino P. Nanocrystals of poorly soluble drugs: drug bioavailability and physicochemical stability. Pharmaceutics. 2018;10(3):134. https:\/\/doi.org\/10.3390\/pharmaceutics10030134.","journal-title":"Pharmaceutics"},{"key":"6877_CR66","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.ijbiomac.2022.09.250","volume":"22","author":"S Kumbham","year":"2022","unstructured":"Kumbham S, Ghosh A, Ghosh B, Biswas S. Human serum albumin-poly(Lactide)-conjugated self-assembly NPs for targeted docetaxel delivery and improved therapeutic efficacy in oral cancer. Int J Biol Macromol. 2022;22:1287\u2013303. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.09.250.","journal-title":"Int J Biol Macromol"},{"key":"6877_CR67","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/nano.202300038","volume":"4","author":"B Mekuye","year":"2023","unstructured":"Mekuye B, Abera B. Nanomaterials: an overview of synthesis, classification, characterization, and applications. Nano Select. 2023;4:486\u2013501. https:\/\/doi.org\/10.1002\/nano.202300038.","journal-title":"Nano Select"},{"key":"6877_CR68","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/B978-0-323-52725-5.00005-8","volume-title":"Multifunctional systems for combined delivery, biosensing and diagnostics","author":"M Gumustas","year":"2017","unstructured":"Gumustas M, Sengel-Tyrk CT, Gumustas A, Ozkan SA, Uslu B. Chapter 5\u2014Effect of polymer-based nanoparticles on the assay of antimicrobial drug delivery systems. In: Multifunctional systems for combined delivery, biosensing and diagnostics. Amsterdam: Elsevier; 2017. p. 67\u2013108. https:\/\/doi.org\/10.1016\/B978-0-323-52725-5.00005-8."},{"key":"6877_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nano9010096","volume":"9","author":"DM Teleanu","year":"2019","unstructured":"Teleanu DM, Chircov C, Grumezescu AM, Teleanu RL. Neurotoxicity of nanomaterials: an up-to-date overview. Nanomaterials. 2019;9:1\u201314. https:\/\/doi.org\/10.3390\/nano9010096.","journal-title":"Nanomaterials"},{"key":"6877_CR70","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.3390\/ma13112586","volume":"13","author":"S Dd Caspani","year":"2020","unstructured":"Dd Caspani S, Magalh\u00e3es R, Ara\u00fajo JP, Sousa CT. Magnetic nanomaterials as contrast agents for MRI. Materials. 2020;13:2586. https:\/\/doi.org\/10.3390\/ma13112586.","journal-title":"Materials"},{"key":"6877_CR71","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/bios14020067","volume":"27","author":"NC Godja","year":"2024","unstructured":"Godja NC, Munteanu FD. Hybrid nanomaterials: a brief overview of versatile solutions for sensor technology in healthcare and environmental applications. Biosensors. 2024;27:67. https:\/\/doi.org\/10.3390\/bios14020067.","journal-title":"Biosensors"},{"key":"6877_CR72","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1080\/10717544.2022.2039804","volume":"29","author":"JJ Xu","year":"2022","unstructured":"Xu JJ, Zhang WC, Guo YW, Chen XY, Zhang YN. Metal nanoparticles as a promising technology in targeted cancer treatment. Drug Deliv. 2022;29:664\u201378. https:\/\/doi.org\/10.1080\/10717544.2022.2039804.","journal-title":"Drug Deliv"},{"key":"6877_CR73","doi-asserted-by":"publisher","first-page":"153303382311520","DOI":"10.1177\/15330338231152083","volume":"22","author":"U Dristant","year":"2023","unstructured":"Dristant U, Mukherjee K, Saha S, Maity D. An overview of polymeric nanoparticles-based drug delivery system in cancer treatment. Technol Cancer Res Treat. 2023;22:15330338231152084. https:\/\/doi.org\/10.1177\/15330338231152083.","journal-title":"Technol Cancer Res Treat"},{"key":"6877_CR74","doi-asserted-by":"publisher","first-page":"869269","DOI":"10.1155\/2014\/869269","volume":"2014","author":"RK Upadhyay","year":"2014","unstructured":"Upadhyay RK. Drug delivery systems, CNS protection, and the blood brain barrier. Biomed Res Int. 2014;2014:869269. https:\/\/doi.org\/10.1155\/2014\/869269.","journal-title":"Biomed Res Int"},{"key":"6877_CR75","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.3390\/ijms23084153","volume":"9","author":"AM Hersh","year":"2022","unstructured":"Hersh AM, Alomari S, Tyler BM. Crossing the blood-brain barrier: advances in nanoparticle technology for drug delivery in neuro-oncology. Int J Mol Sci. 2022;9:4153. https:\/\/doi.org\/10.3390\/ijms23084153.","journal-title":"Int J Mol Sci"},{"key":"6877_CR76","doi-asserted-by":"publisher","first-page":"100231","DOI":"10.1016\/j.ijpx.2024.100231","volume":"7","author":"Rarokar","year":"2024","unstructured":"Rarokar, et al. Magnetic nanosystem a tool for targeted delivery and diagnostic application: Current challenges and recent advancement. Int J Pharm: X. 2024;7:100231. https:\/\/doi.org\/10.1016\/j.ijpx.2024.100231.","journal-title":"Int J Pharm: X"},{"key":"6877_CR77","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1038\/s41467-020-18525-2","volume":"11","author":"K Hou","year":"2020","unstructured":"Hou K, Zhao J, Wang H, et al. Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer\u2019s disease. Nat Commun. 2020;11:4790. https:\/\/doi.org\/10.1038\/s41467-020-18525-2.","journal-title":"Nat Commun"},{"issue":"10","key":"6877_CR78","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s11671-015-0823-5","volume":"1","author":"K Urba\u0144ska","year":"2015","unstructured":"Urba\u0144ska K, Paj\u0105k B, Orzechowski A, Soko\u0142owska J, Grodzik M, Sawosz E, Szmidt M, Sysa P. The effect of silver nanoparticles (AgNPs) on proliferation and apoptosis of in ovo cultured glioblastoma multiforme (GBM) cells. Nanoscale Res Lett. 2015;1(10):98. https:\/\/doi.org\/10.1186\/s11671-015-0823-5.","journal-title":"Nanoscale Res Lett"},{"key":"6877_CR79","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3109\/03639045.2012.681054","volume":"39","author":"YZ Zhou","year":"2012","unstructured":"Zhou YZ, Alany RG, Chuang V, Wen J. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design. Drug Dev Ind Pharm. 2012;39:321\u201330. https:\/\/doi.org\/10.3109\/03639045.2012.681054.","journal-title":"Drug Dev Ind Pharm"},{"key":"6877_CR80","doi-asserted-by":"publisher","first-page":"115101","DOI":"10.1088\/0957-4484\/20\/11\/115101","volume":"20","author":"X Deng","year":"2009","unstructured":"Deng X, Luan Q, Chen W, Wang Y, Wu M, Zhang H, Jia Z. Nanosized zinc oxide particles induce neural stem cell apoptosis. Nanotechnology. 2009;20:115101. https:\/\/doi.org\/10.1088\/0957-4484\/20\/11\/115101.","journal-title":"Nanotechnology"},{"issue":"3","key":"6877_CR81","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1128\/CMR.00070-09","volume":"23","author":"MC Brouwer","year":"2010","unstructured":"Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23(3):467\u201392. https:\/\/doi.org\/10.1128\/CMR.00070-09.","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"6877_CR82","first-page":"708","volume":"91","author":"DB Middleton","year":"2015","unstructured":"Middleton DB, Mackinnon DR, Moorehead JF. Carpal tunnel syndrome: what you should know. Am Fam Physician. 2015;91(10):708\u201314.","journal-title":"Am Fam Physician"},{"issue":"16","key":"6877_CR83","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1503\/cmaj.140455","volume":"187","author":"N Jette","year":"2015","unstructured":"Jette N, Reid AY, Wiebe S. Surgical management of epilepsy. Can Med Assoc J. 2015;187(16):1219\u201325. https:\/\/doi.org\/10.1503\/cmaj.140455.","journal-title":"Can Med Assoc J"},{"issue":"10130","key":"6877_CR84","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","volume":"391","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018;391(10130):1622\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(18)30481-1.","journal-title":"Lancet"},{"issue":"1","key":"6877_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12179","volume":"7","author":"J Cummings","year":"2021","unstructured":"Cummings J, Lee G, Zhong K, Fonseca J, Taghva K. Alzheimer\u2019s disease drug development pipeline: 2021. Alzheimer\u2019s Dementia: Transl Res Clin Interv. 2021;7(1): e12179. https:\/\/doi.org\/10.1002\/trc2.12179.","journal-title":"Alzheimer's Dementia: Transl Res Clin Interv"},{"issue":"8","key":"6877_CR86","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00702-017-1717-8","volume":"124","author":"B Heim","year":"2017","unstructured":"Heim B, Krismer F, De Marzi R, Seppi K. Magnetic resonance imaging for the diagnosis of Parkinson\u2019s disease. J Neural Transm. 2017;124(8):915\u201364. https:\/\/doi.org\/10.1007\/s00702-017-1717-8.","journal-title":"J Neural Transm"},{"issue":"1","key":"6877_CR87","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-publhealth-040617-014158","volume":"39","author":"R Ramaswami","year":"2018","unstructured":"Ramaswami R, Bayer R, Galea S. Precision medicine from a public health perspective. Annu Rev Public Health. 2018;39(1):153\u201368. https:\/\/doi.org\/10.1146\/annurev-publhealth-040617-014158.","journal-title":"Annu Rev Public Health"},{"key":"6877_CR88","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.nbd.2017.12.001","volume":"110","author":"I Waltl","year":"2018","unstructured":"Waltl I, et al. Macrophage depletion by liposome-encapsulated clodronate suppresses seizures but not hippocampal damage after acute viral encephalitis. Neurobiol Dis. 2018;110:192\u2013205. https:\/\/doi.org\/10.1016\/j.nbd.2017.12.001.","journal-title":"Neurobiol Dis"},{"key":"6877_CR89","doi-asserted-by":"publisher","first-page":"12467","DOI":"10.1021\/acsomega.0c01305","volume":"5","author":"MR Mungroo","year":"2020","unstructured":"Mungroo MR, Anwar A, Khan NA, Siddiqui R. God-conjugated curcumin as a novel therapeutic agent against brain-eating amoebae. ACS Omega. 2020;5:12467\u201375.","journal-title":"ACS Omega"},{"key":"6877_CR90","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1203\/PDR.0b013e3181d6245e","volume":"67","author":"V Maojo","year":"2010","unstructured":"Maojo V, Martin-Sanchez F, Kulikowski C, Rodriguez-Paton A, Fritts M. Nanoinformatics and DNA-based computing: catalyzing nanomedicine. Pediatr Res. 2010;67:481\u20139.","journal-title":"Pediatr Res"},{"key":"6877_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmats.2022.857385","volume":"9","author":"D Nie","year":"2022","unstructured":"Nie D, Zhu Y, Guo T, Yue M, Lin M. Research advance in Manganese nanoparticles in cancer diagnosis and therapy. Front Mater. 2022;9:1\u201315. https:\/\/doi.org\/10.3389\/fmats.2022.857385.","journal-title":"Front Mater"},{"key":"6877_CR92","doi-asserted-by":"publisher","first-page":"120978","DOI":"10.1016\/j.ijpharm.2021.120978","volume":"607","author":"Lan","year":"2021","unstructured":"Lan, et al. Disulfiram-loaded copper sulfide nanoparticles for potential anti-glioma therapy. Int J Pharm. 2021;607:120978. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120978.","journal-title":"Int J Pharm"},{"key":"6877_CR93","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.3390\/ijms21062108","volume":"21","author":"W Rozp\u0119dek-Kami\u0144ska","year":"2020","unstructured":"Rozp\u0119dek-Kami\u0144ska W, Siwecka N, Wawrzynkiewicz A, Wojtczak R, Pytel D, Diehl JA, Majsterek I. The PERK-dependent molecular mechanisms as a novel therapeutic target for neurodegenerative diseases. Int J Mol Sci. 2020;21:2108. https:\/\/doi.org\/10.3390\/ijms21062108.","journal-title":"Int J Mol Sci"},{"key":"6877_CR94","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/eng6050082","volume":"6","author":"N Musthafa","year":"2025","unstructured":"Musthafa N, Memon QA, Masud MM. Advancing brain tumor analysis: current trends, key challenges, and perspectives in deep learning-based brain MRI tumor diagnosis. Eng. 2025;6:82. https:\/\/doi.org\/10.3390\/eng6050082.","journal-title":"Eng"},{"issue":"9","key":"6877_CR95","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.mpmed.2020.06.002","volume":"48","author":"SJX Murphy","year":"2020","unstructured":"Murphy SJX, Werring DJ. Stroke: causes and clinical features. Medicine. 2020;48(9):561\u20136. https:\/\/doi.org\/10.1016\/j.mpmed.2020.06.002.","journal-title":"Medicine"},{"issue":"5","key":"6877_CR96","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/00004647-200405000-00001","volume":"24","author":"GE Nilsson","year":"2004","unstructured":"Nilsson GE, Lutz PL. Anoxia tolerant brains. J Cereb Blood Flow Metab. 2004;24(5):475\u201386. https:\/\/doi.org\/10.1097\/00004647-200405000-00001.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"6877_CR97","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/OGX.0000000000000236","volume":"70","author":"CN Cordeiro","year":"2015","unstructured":"Cordeiro CN, Tsimis M, Burd I. Infections and brain development. Obstetrical Gynecol Surv. 2015;70(10):644\u201355. https:\/\/doi.org\/10.1097\/OGX.0000000000000236.","journal-title":"Obstetrical Gynecol Surv"},{"issue":"1562","key":"6877_CR98","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1098\/rstb.2010.0230","volume":"366","author":"JE Risdall","year":"2011","unstructured":"Risdall JE, Menon DK. Traumatic brain injury. Philos Trans Royal Soc B Biol Sci. 2011;366(1562):241\u201350. https:\/\/doi.org\/10.1098\/rstb.2010.0230.","journal-title":"Philos Trans Royal Soc B Biol Sci"},{"key":"6877_CR99","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.3390\/nano12132140","volume":"12","author":"A Waris","year":"2022","unstructured":"Waris A, Ali A, Khan AU, Asim M, Zamel D, Fatima K, Raziq A, Khan MA, Akbar N, Baset A, et al. Applications of various types of nanomaterials for the treatment of neurological disorders. Nanomaterials. 2022;12:2140. https:\/\/doi.org\/10.3390\/nano12132140.","journal-title":"Nanomaterials"},{"key":"6877_CR100","doi-asserted-by":"publisher","first-page":"114636","DOI":"10.1016\/j.addr.2022.114636","volume":"192","author":"B Conklin","year":"2023","unstructured":"Conklin B, et al. Advanced theragnostics for the central nervous system (CNS) and neurological disorders using functional inorganic nanomaterials. Adv Drug Deliv Rev. 2023;192:114636. https:\/\/doi.org\/10.1016\/j.addr.2022.114636.","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06877-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06877-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06877-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T10:15:22Z","timestamp":1764584122000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06877-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6877"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06877-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. The authors confirm that they have no personal or financial interests that might bias the objectivity of the research findings.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1366"}}